Market Research Logo

Global Cancer Biomarker Market Forecast 2017-2025

Global Cancer Biomarker Market Forecast 2017-2025KEY FINDINGS

The global cancer biomarker market is expected to grow at a CAGR of 14.07% between the years 2017- 2025, generating a net worth of $33026 million by the end of 2025. Some of the important drivers for the global biomarker market include encouragement by the FDA for biomarker development, the adoption of western lifestyles in developing countries, heavy investments by government and private funds for cancer-related research, etc. At present, the genetic and genomic biomarkers are the leading revenue generating segment of the market

MARKET INSIGHTS

The Global cancer biomarker market is segmented on the basis of the Discovery and Diagnostics and on the basis of the Diseases. The discovery and diagnostics segment is sub-divided into Biomarker discovery and Diagnostics. The biomarkers discovery is further sub-segmented into imaging, genetic methods, protein methods, and metabolomics; whereas the Diagnostic market is sub-segmented into proteomics, genetic and genomic markers, DNA microarrays, immunohistochemical tests, immunoassays, pharmacogenomics, molecular diagnostic assays, monoclonal antibodies, flow cytometry, stem cell markers etc. The Diseases segment is further sub-segmented into various types of cancers such as breast cancer, lung cancer, colorectal cancer, cervical cancer, prostate cancer, etc

REGIONAL INSIGHTS

The global cancer biomarker market is geographically segmented into North America (U.S. & Canada), Asia-Pacific (India, China, Japan, Australia, South Korea, and Rest of APAC), Europe (United Kingdom, Germany, Italy, France, Spain, rest of Europe) and the Rest of World (Latin America, Middle East and North Africa and Rest of Africa). The North American region is the most dominant region in the global market, with the United States acting as the major contributor. Moreover, the Asia-Pacific region is anticipated to be the fastest growing regional market owing to the increasing prevalence of cancer in the region.

COMPETITIVE INSIGHTS

Some of the noted companies in the global market are Abbott Laboratories, Agendia N.V, Affymetrix, Inc.(Acquired By Thermofisher), Agilent Technologies, Inc, Becton Dickinson And Company, Astellas Pharma Inc, Clarient, Inc. (Acquired By Neogenomics Laboratories), Illumina, Inc, Diadexus Inc (Acquired By Diazyme Laboratories), Qiagen N.V, Roche Diagnostics Ltd, Aureon Biosciences, Inc, Biomoda Inc and Ambrilia Biopharma Inc.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Key Findings
3.1.1. North America Is The Market Leader
3.1.2. India Is The Fastest Growing Market For Cancer Biomarkers
3.1.3. Genetic And Genomic Markers Biomarker Is The Leading Revenue Generating Biomarker Discovery
4. Market Determinants
4.1. Market Drivers
4.1.1. Adoption Of Western Lifestyles In Developing Regions
4.1.2. Growing Prevalence On Research Of Cancer Biomarkers
4.1.3. Encouragement For Biomarker Development By Fda
4.1.4. Improved Precision And Speed Of Diagnosis
4.1.5. High Investment Through Government And Private Funds In Cancer Related Research
4.1.6. Development Of Highly Specific Drugs
4.2. Restraints
4.2.1. Poor Compensation Structures
4.2.2. Low Estimated Rate Of Successful Clinical Trials Of Biomarkers
4.2.3. Technical Issues Related To Cancer Biomarkers
4.3. Market Opportunities
4.3.1. Wide Opportunity To Grow In Personalized Medication
4.3.2. Supports On Biomarkers Test
4.3.3. Growing Number Of Cancer Patients And Growing Medical Tourism In Emerging Economies
4.4. Market Challenges
4.4.1. Lacking Acceptance Of The Cancer Biomarker
4.4.2. Unfavorable Compensation Situation
4.4.3. High Cost Of Developing Companion Diagnostics
4.4.4. Rigorous Regulatory Agenda
4.4.5. Dearth Of Skilful Workers
5. Market Segmentation
5.1. Market By Discovery And Diagnostics 2017-2025
5.1.1. Biomarker Discovery
5.1.1.1. Genetic Methods
5.1.1.1.1. Dna Arrays
5.1.1.1.2. Polymerase Chain Reaction (Pcr)
5.1.1.1.3. Reverse Transcriptase Polymerase Chain Reaction (Rt-pcr)
5.1.1.1.4. Fluorescent In Situ Hybridization (Fish)
5.1.1.1.5. Southern Blot
5.1.1.2. Imaging
5.1.1.2.1. Magnetic Resonance Imaging (Mri)
5.1.1.2.2. Computed Tomography (Ct)
5.1.1.2.3. Positron Emission Tomography (Pet)
5.1.1.2.4. Ultrasound
5.1.1.2.5. Single-photon Emission Computed Tomography (Spect)
5.1.1.2.6. X-ray
5.1.1.2.7. Magnetic Resonance Spectroscopy (Mrs)
5.1.1.2.8. Biophotonics
5.1.1.3. Protein Methods
5.1.1.3.1. Mass Spectrometry (Ms)
5.1.1.3.2. Immunohistochemistry (Ihc)
5.1.1.4. Metabolomics
5.1.2. Biomarker Diagnostic
5.1.2.1. Genetic And Genomic Markers
5.1.2.2. Proteomics
5.1.2.3. Dna Microarrays
5.1.2.4. Immunoassays
5.1.2.5. Immunohistochemical Tests
5.1.2.6. Pharmacogenomics
5.1.2.7. Molecular (Dna And Genomic) Diagnostic Assays
5.1.2.8. Flow Cytometry
5.1.2.9. Monoclonal Antibodies
5.1.2.10. Stem Cell Markers
5.1.2.11. Invitro Diagnostic Multivariate Index
5.2. Market By Disease 2017-2025
5.2.1. Lung Cancer
5.2.2. Breast Cancer
5.2.3. Colorectal Cancer
5.2.4. Prostate Cancer
5.2.5. Cervical Cancer
5.2.6. Other Cancer
6. Key Analytics
6.1. Porters Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Product
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Suppliers
6.1.5. Intensity Of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Pricing
6.3.2. Efficacy
6.3.3. Application And Effectiveness
6.4. Vendor Landscape
7. Geographic Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom (Uk)
7.2.2. France
7.2.3. Germany
7.2.4. Spain
7.2.5. Italy
7.2.6. Rest Of Europe
7.3. Asia-pacific
7.3.1. China
7.3.2. India
7.3.3. Japan
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest Of Asia-pacific
7.4. Rest Of The World
7.4.1. Latin America
7.4.2. Middle East And North Africa (Mena)
7.4.3. Rest Of Africa
8. Company Profiling
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.1.2. Top Winning Strategies
8.2. Abbott Laboratories
8.2.1. Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Affymetrix, Inc.(Acquired By Thermofisher)
8.3.1. Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Agendia N.V.
8.4.1. Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Agilent Technologies, Inc.
8.5.1. Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Astellas Pharma Inc.
8.6.1. Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Becton Dickinson And Company
8.7.1. Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Clarient, Inc. (Acquired By Neogenomics Laboratories)
8.8.1. Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Diadexus Inc. (Acquired By Diazyme Laboratories)
8.9.1. Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc
8.10.1. Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Qiagen N.V. Overview
8.11.1. Product Portfolio
8.11.2. Scot Analysis
8.11.3. Strategic Initiatives
8.12. Roche Diagnostics Ltd
8.12.1. Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Ambrilia Biopharma Inc.
8.13.1. Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Aureon Biosciences, Inc
8.14.1. Beckman Coulter Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Biomoda Inc.
8.15.1. Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table # 1 Recent Research On Biomarkers
Table # 2 List Of Fda Approved Protein Cancer Biomarkers (2015)
Table # 3 Potential Clinical Use Of Cancer Biomarkers
Table # 4 Medical Tourism Prices In Us Dollar
Table # 5 Global Cancer Biomarker Market, By Discovery And Diagnostics 2017-2025 ($million)
Table # 6 Global Genetic Methods Market 2017-2025 ($million)
Table # 7 Global Genetic Methods Market, By Geography 2017-2025 ($million)
Table # 8 Global Dna Arrays Market, By Region 2017-2025 ($million)
Table # 9 Global Polymerase Chain Reaction Market, By Region 2017-2025 ($million)
Table # 10 Global Reverse Transcriptase Polymerase Chain Reaction Market, By Region 2017-2025 ($million)
Table # 11 Global Fluorescent In Situ Hybridization Market, By Region 2017-2025 ($million)
Table # 12 Global Southern Blot Market, By Region 2017-2025 ($million)
Table # 13 Global Imaging Market 2017-2025 ($million)
Table # 14 Global Imaging Market, By Region 2017-2025 ($million)
Table # 15 Global Magnetic Resonance Imaging Market, By Region 2017-2025 ($million)
Table # 16 Global Computed Tomography Market, By Region 2017-2025 ($million)
Table # 17 Global Positron Emission Tomography Market, By Region 2017-2025 ($million)
Table # 18 Global Ultrasound Market, By Region 2017-2025 ($million)
Table # 19 Global Single Photon Emission Computed Tomography Market, By Region 2017-2025 ($million)
Table # 20 Global X-ray Market, By Region 2017-2025 ($million)
Table # 21 Global Magnetic Resonance Spectroscopy Market, By Region 2017-2025 ($million)
Table # 22 Global Biophotonics Market, By Region 2017-2025 ($million)
Table # 23 Global Protein Methods Market 2017-2025 ($million)
Table # 24 Global Protein Methods Market, By Region 2017-2025 ($million)
Table # 25 Global Mass Spectrometry Market,By Region 2017-2025 ($million)
Table # 26 Global Immunohistochemistry Market, By Region 2017-2025 ($million)
Table # 27 Global Metabolomics Market, By Region 2017-2025 ($million)
Table # 28 Global Biomarker Diagnostic Market, 2017-2025 ($million)
Table # 29 Global Genomics And Genetic Markers Market, By Region 2017-2025 ($million)
Table # 30 Global Proteomics Market, By Region 2017-2025 ($million)
Table # 31 Global Dna Microarrays Market, By Region 2017-2025 ($million)
Table # 32 Global Immunoassays Market, By Region 2017-2025 ($million)
Table # 33 Global Immunohistochemical Tests Market, By Region 2017-2025 ($million)
Table # 34 Global Pharmacogenomics Market, By Region 2017-2025 ($million)
Table # 35 Global Molecular (Dna And Genomic) Diagnostic Assays Market, By Region 2017-2025 ($million)
Table # 36 Global Flow Cytometry Market, By Region 2017-2025 ($million)
Table # 37 Global Monoclonal Antibodies Market, By Region 2017-2025 ($million)
Table # 38 Global Stem Cell Markers Market, By Region 2017-2025 ($million)
Table # 39 Global In Vitro Diagnostic Multivariate Index Assays Market, By Region 2017-2025 ($million)
Table # 40 Global Cancer Biomarkers Market, By Disease 2017-2025 ($million)
Table # 41 Global Lung Cancer Market, By Region 2017-2025 ($million)
Table # 42 Global Breastcancer Market, By Region 2017-2025 ($million)
Table # 43 Global Colorectal Cancer Market, By Region 2017-2025 ($million)
Table # 44 Global Prostate Cancer Market, By Region 2017-2025 ($million)
Table # 45 Human Specimens For Cancer Biomarker Discovery
Table # 46 Global Cervical Cancer Market, By Region 2017-2025 ($million)
Table # 47 List Of Fda-qualified Biomarkers
Table # 48 Global Other Cancer Market, By Region 2017-2025 ($million)
Table # 49 Estimated New Cancer Cases And Deaths For 2017, By Sex
Table # 50 Global Cancer Biomarkers Market, By Region 2017-2025($ Million)
Table # 51 North America Cancer Biomarkers Market 2017-2025 ($ Million)
Table # 52 Europe Cancer Biomarkers Market 2017-2025 ($ Million)
Table # 53 Asia-pacific Cancer Biomarkers Market 2017-2025 ($ Million)
Table # 54 Row Cancer Biomarkers Market 2017-2025 ($ Million)
Figure List
Figure # 1 Increasing Number Of People Living With Cancer Across The Globe For Period 2012-2020 (Million)
Figure # 2 Most Common Cancer Causing Deaths In 2015
Figure # 3 Pharmacogenomic Biomarkers Information In Drug Labeling
Figure # 4 Percentage Of Patients Ineffective For Particular Drug
Figure # 5 List Of Cleared Or Approved Companion Diagnostic Devices (Imaging Tools And In Vitro) By Fda
Figure # 6 Global Genetic Methods Market 2017-2025 ($million)
Figure # 7 Global Dna Arrays Market 2017-2025 ($million)
Figure # 8 Global Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 9 Global Reverse Transcriptase Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 10 Global Fluorescent In Situ Hybridization Market 2017-2025 ($million)
Figure # 11 Global Southern Blot Market 2017-2025 ($million)
Figure # 12 Global Imaging Market 2017-2025 ($million)
Figure # 13 Global Magnetic Resonance Imaging Market 2017-2025 ($million)
Figure # 14 Global Computed Tomography Market 2017-2025 ($million)
Figure # 15 Global Positron Emission Tomography Market 2017-2025 ($million)
Figure # 16 Global Ultrasound Market 2017-2025 ($million)
Figure # 17 Global Single Photon Emission Computed Tomography Market 2017-2025 ($million)
Figure # 18 Global X-ray Market 2017-2025 ($million)
Figure # 19 Global Magnetic Resonance Spectroscopy Market 2017-2025 ($million)
Figure # 20 Global Biophotonics Market 2017-2025 ($million)
Figure # 21 Global Protein Methods Market 2017-2025 ($million)
Figure # 22 Global Mass Spectrometry Market 2017-2025 ($million)
Figure # 23 Global Immunohistochemistry Market 2017-2025 ($million)
Figure # 24 Global Metabolomics Market 2017-2025 ($million)
Figure # 25 Global Genomics And Genetic Markers Market 2017-2025 ($million)
Figure # 26 Global Proteomics Market 2017-2025 ($million)
Figure # 27 Global Dna Microarrays Market 2017-2025 ($million)
Figure # 28 Global Immunoassays Market 2017-2025 ($million)
Figure # 29 Global Immunohistochemical Tests Market 2017-2025 ($million)
Figure # 30 Global Pharmacogenomics Market 2017-2025 ($million)
Figure # 31 Global Molecular (Dna And Genomic) Diagnostic Assays Market 2017-2025 ($million)
Figure # 32 Global Flow Cytometry Market 2017-2025 ($million)
Figure # 33 Global Monoclonal Antibodies Market 2017-2025 ($million)
Figure # 34 Global Stem Cell Markers Market 2017-2025 ($million)
Figure # 35 Global In Vitro Diagnostic Multivariate Index Assays Market 2017-2025 ($million)
Figure # 36 Global Lung Cancer Market, By Region 2017-2025 ($million)
Figure # 37 New Cases Of Lung & Bronchus Cancer And Associated Deaths, 2015
Figure # 38 Global Breastcancer Market 2017-2025 ($million)
Figure # 39 Global Colorectal Cancer Market 2017-2025 ($million)
Figure # 40 Statistics Of Colorectal Cancer In 2016
Figure # 41 Global Prostate Cancer Market 2017-2025 ($million)
Figure # 42 Global Cervical Cancer Market 2017-2025 ($million)
Figure # 43 Global Other Cancer Market 2017-2025 ($million)
Figure # 44 United States Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 45 Canada Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 46 Percentage Vise Distribution Of Various Cancers England (2015)
Figure # 47 Uk Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 48 Healthcare Spending Per Capita $
Figure # 49 France Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 50 Germany Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 51 Spain Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 52 Italy Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 53 Rest Of Europe Biomarkers Market 2017-2025 ($ Million)
Figure # 54 China Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 55 India Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 56 Japan Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 57 South Korea Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 58 Australia Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 59 Rest Of Asia-pacific Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 60 Latin America Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 61 Mena Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 62 Rest Of Africa Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 63 Market Share Analysis Of Key Players 2016 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report